The Immunomodulatory Functions of Butyrate
Open accessThe DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Abstract
The gastrointestinal (GI) system contains many different types of immune cells, making it a key immune organ system in the human body. In the last decade, our knowledge has substantially expanded regarding our understanding of the gut microbiome and its complex interaction with the gut immune system. Short chain fatty acids (SCFA), and specifically butyrate, play an important role in mediating the effects of the gut microbiome on local and systemic immunity. Gut microbial alterations and depletion of luminal butyrate have been well documented in the literature for a number of systemic and GI inflammatory disorders. Although a substantial knowledge gap exists requiring the need for further investigations to determine cause and effect, there is heightened interest in developing immunomodulatory therapies by means of reprogramming of gut microbiome or by supplementing its beneficial metabolites, such as butyrate. In the current review, we discuss the role of endogenous butyrate in the inflammatory response and maintaining immune homeostasis within the intestine. We also present the experimental models and human studies which explore therapeutic potential of butyrate supplementation in inflammatory conditions associated with butyrate depletion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fiber-rich, plant-based diets have the opposite effect, nurturing Bifidobacterium and Lactobacillus, increasing butyrate producers like Roseburia and Eubacterium rectale, and shielding against obesity and insulin resistance via SCFA signaling.15,70,81–83”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Han, R., Sun, Q., Wu, J., Zheng, P., & Zhao, G. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000447889 · Cited by 65
RetractedStructure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549 · cited 1×
“T and B Lymphocytes Independent of its immunomodulatory effects mediated by DC and macrophages, butyrate also has dose-dependent direct effects on T lymphocytes.(89,94,95) By utilizing a combination of both in-vivo and in-vitro experiments, Arpaia et al concluded that butyrate can boost extrathymic Treg-cell generatio…”
BackgroundRevised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413 · cited 1×
“Smith et al reported that 150mM of butyrate supplementation in drinking water resulted in increased colonic regulatory T cells (cTregs) frequency and number in the germ free mice.(124) Similarly, in another study byZhang et al, they studied the effect of butyrate supplementation in a rat model of colitis and reported…”
BackgroundMetabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838 · cited 4×
“Butyrate in Intestinal Immunity – Adaptive Butyrate has been shown to play an important role in an adaptive immune response via two distinct pathways: firstly, from the effect of butyrate on monocyte-derived dendritic cells (DC), and secondly, through butyrate’s direct effect on T lymphocytes.(89,90)”
BackgroundMethodInfluentialWnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Nusse, R., & Clevers, H. (2017) · Cell · doi:10.1016/j.cell.2017.05.016 · Cited by 4,342
Parada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00277 · Cited by 3,820
Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G. A. D., Gasbarrini, A., & Mele, M. C. (2019) · Microorganisms · doi:10.3390/microorganisms7010014 · Cited by 3,462 · cited 2×
“a commensal blend of bacteria, fungi (mostly yeasts), viruses/phages, archaea, and parasites.(1) The gut microbiome is a term used to describe the genetic and”
BackgroundThe role of short-chain fatty acids in microbiota–gut–brain communication
Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0157-3 · Cited by 3,357 · cited 2×
“used as an energy substrate for hepatocytes, thus leaving very little butyrate in the systemic circulation.(19) However,”
BackgroundMethodInflammasomes: mechanism of action, role in disease, and therapeutics
Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340 · cited 3×
“In a DSSinduced colitis model in male outbred-CD-1 mice, the dietary provision of baked corn and bean snack (20–40 g/kg body weight) resulted in the highest concentration of butyrate in the cecum and feces, and an anti-inflammatory effect by downregulating IL-1 receptor, TLR receptors and TNF-alpha pathways.123 Smith…”
BackgroundInfluentialBrown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P. D., Manicassamy, S., Munn, D. H., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.007 · Cited by 2,368 · cited 3×
“When subjected to chemically-induced colonic inflammation and cancer with dextran sodium sulfate (DSS) and azoxymethane (AOM), GPR109a mice had exacerbated inflammation and colon carcinogenesis, suggesting the importance of GPR109a in promoting anti-inflammatory properties and colonic homeostasis.(33) Further studies…”
BackgroundNasir, O. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000350152 · Cited by 2,331
Chang, P. V., Hao, L., Offermanns, S., & Medzhitov, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322269111 · Cited by 2,175 · cited 5×
“In bone marrowderived macrophages stimulated with LPS, butyrate decreased secretion of IL-6, IL-12p40, and nitric oxide to a greater extent than acetate or propionate in a dose dependent manner, suggesting butyrate has anti-inflammatory effects on macrophages.(30) Butyrate treatment in macro-”
BackgroundResultInfluentialPeng, L., Li, Z.-R., Green, R. S., Holzmanr, I. R., & Lin, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.104638 · Cited by 2,130 · cited 1×
“Increased TJ reassembly and TER restoration was due to butyrate’s induction of AMP-activated protein kinase (AMPK) activity.(41,43,46) During exposure to LPS, butyrate’s protection against LPS-induced TER reduction and paracellular permeability coincided with less activation of NLRP3 inflammasome and autophagy via but…”
BackgroundMachiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904 · cited 1×
“of IBD, a reduction in butyrate producing gut microbes has been reported.(107,108) As it has been described in our previous detailed discussion in this review, butyrate has”
Regional specialization within the intestinal immune system
Mowat, A. M., & Agace, W. W. (2014) · Nature Reviews Immunology · doi:10.1038/nri3738 · Cited by 1,756 · cited 3×
“A detailed review of the intestinal immune system can be found in Mowat et al.40”
BackgroundInfluentialRivière, A., Selak, M., Lantin, D., Leroy, F., & De Vuyst, L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00979 · Cited by 1,726 · cited 1×
“producing bacteria as a functional group rather than a coherent phylogenic group.(12) Predominating within the”
BackgroundKelly, C. J., Zheng, L., Campbell, E. L., Saeedi, B., Scholz, C. C., Bayless, A. J., Wilson, K. E., Glover, L. E., Kominsky, D. J., Magnuson, A., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.03.005 · Cited by 1,716 · cited 1×
“Butyrate has also been shown to stabilize hypoxia-inducible factor (HIF), a transcription factor that coordinates low oxygen in the colonic epithelium to regulate intestinal barrier function.(47) Positive effects of butyrate on TJ proteins are dose dependent, with lower doses demonstrating benefit.”
BackgroundThe biology of innate lymphoid cells
Artis, D., & Spits, H. (2015) · Nature · doi:10.1038/nature14189 · Cited by 1,634 · cited 2×
“genous mammalian cell-derived factors and integrate innate and adaptive immune responses to assist in maintaining physiological homeostasis.(80) Nontoxic ILCs consist of three distinct groups: ILC1, 2, and 3 and are defined based on their transcription factor requirements, effector cytokine expression, and other disti…”
BackgroundACG Clinical Guideline: Ulcerative Colitis in Adults
Rubin, D. T., Ananthakrishnan, A. N., Siegel, C. A., Sauer, B. G., & Long, M. D. (2019) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000152 · Cited by 1,577 · cited 2×
“In 1992 Scheppach et al performed a clinical trial in which 100mMol/L of butyrate via rectal enema was compared with placebo for distal ulcerative colitis and reported that butyrate improved all parameters related to colitis including clinical indices with decreased stool frequency and blood in stool, and endoscopic a…”
BackgroundPotential beneficial effects of butyrate in intestinal and extraintestinal diseases
Canani, R. B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i12.1519 · Cited by 1,381
Regulation of immune cell function by short‐chain fatty acids
Corrêa‐Oliveira, R., Fachi, J. L., Vieira, A., Sato, F. T., & Vinolo, M. A. R. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.17 · Cited by 1,346 · cited 3×
“Butyrate in Intestinal Immunity – Adaptive Butyrate has been shown to play an important role in an adaptive immune response via two distinct pathways: firstly, from the effect of butyrate on monocyte-derived dendritic cells (DC), and secondly, through butyrate’s direct effect on T lymphocytes.(89,90)”
BackgroundButyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease
Segain, J.-P., de la Blétière, D. R., Bourreille, A., Leray, V, Gervois, N., Rosales, C., Ferrier, L., Bonnet, C., Blottière, H. M., & Galmiche, J.-P. (2000) · Gut · doi:10.1136/gut.47.3.397 · Cited by 1,321
Pathophysiology of Inflammatory Bowel Diseases
Chang, J. T. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2002697 · Cited by 1,295
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J. K. M., Doherty, J. M., Mills, J. C., & Colonna, M. (2009) · Nature · doi:10.1038/nature07537 · Cited by 1,251 · cited 2×
“Innate lymphoid cells (ILC) are regulated by multiple endogenous mammalian cell-derived factors and integrate innate and adaptive immune responses to assist in maintaining physiological homeostasis.80 Nontoxic ILCs consist of three distinct groups: ILC1, 2, and 3 and are defined based on their transcription factor req…”
InfluentialKim, M. H., Kang, S. G., Park, J. H., Yanagisawa, M., & Kim, C. H. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.056 · Cited by 1,127 · cited 1×
“These responses were due to activated extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase which were GPR41/43 dependent.(36) GPR109A is highly expressed on innate immune cells and adipose tissue, as well as the apical membrane of intestinal epithelial cells.”
BackgroundIL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
Ouyang, W., & O’Garra, A. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.020 · Cited by 1,072 · cited 1×
“IL-22 aids in protecting the intestine against inflammatory injury by inducing AMPs and supporting the intestinal barrier.(84,85)”
BackgroundYang, W., Yu, T., Huang, X., Bilotta, A. J., Xu, L., Lu, Y., Sun, J., Pan, F., Zhou, J., Zhang, W., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18262-6 · Cited by 1,042 · cited 1×
“tion and GPR41 by promoting aryl hydrocarbon receptor and hypoxia-inducible factor 1α.(83) IL-22 aids in protecting the intestine against inflammatory injury by inducing AMPs and supporting the intestinal barrier.”
BackgroundThe Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages
Schulthess, J., Pandey, S., Capitani, M., Rue-Albrecht, K. C., Arnold, I., Franchini, F., Chomka, A., Ilott, N. E., Johnston, D. G. W., Pires, E., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.018 · Cited by 1,037 · cited 1×
“Acting via its HDAC3 inhibitory function, butyrate drove monocyte to macrophage differentiation and induced macrophage production of AMPs, S100A8 and S100A9 genes and calprotectin expression, in the absence of increased proinflammatory cytokine response, which led to enhanced bactericidal function in vitro and in vivo…”
BackgroundInteraction between the gut microbiome and mucosal immune system
Shi, N., Li, N., Duan, X., & Niu, H. (2017) · Military Medical Research · doi:10.1186/s40779-017-0122-9 · Cited by 940 · cited 1×
“sion, and supporting the intestinal epithelial barrier and immune defenses.(7) The intestinal mucosal immune system”
BackgroundAngiogenins: a new class of microbicidal proteins involved in innate immunity
Hooper, L. V., Stappenbeck, T. S., Hong, C. V., & Gordon, J. I. (2003) · Nature Immunology · doi:10.1038/ni888 · Cited by 929 · cited 1×
“decreased gene expression in germ-free compared to conventional mice.(10) Although the gut microbiome involve-”
BackgroundGut Microbial Metabolites Fuel Host Antibody Responses
Kim, M., Qie, Y., Park, J., & Kim, C. H. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.07.001 · Cited by 893 · cited 1×
“also induce antibody response by stimulating intestinal mucosal IgA responses and systemic IgG responses.(105)”
BackgroundPUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect
Tunaru, S., Kero, J., Schaub, A., Wufka, C., Blaukat, A., Pfeffer, K., & Offermanns, S. (2003) · Nature Medicine · doi:10.1038/nm824 · Cited by 791
Thangaraju, M., Cresci, G. A., Liu, K., Ananth, S., Gnanaprakasam, J. P., Browning, D. D., Mellinger, J. D., Smith, S. B., Digby, G. J., Lambert, N. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4466 · Cited by 789 · cited 2×
“GPR109A is highly expressed on innate immune cells and adipose tissue, as well as the apical membrane of intestinal epithelial cells.(34) GPR109a mice have altered intestinal immune capacity with reduced frequency of Treg and IL-10 producing CD4+ T cells in the colon.”
BackgroundSelf-citationEffect of butyrate enemas on the colonic mucosa in distal ulcerative colitis
Scheppach, W., Sommer, H., Kirchner, T., Paganelli, G.-M., Bartram, P., Christl, S., Richter, F., Dusel, G., & Kasper, H. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91094-k · Cited by 741 · cited 1×
“In 1992 Scheppach et al performed a clinical trial in which 100mMol/L of butyrate via rectal enema was compared with placebo for distal ulcerative colitis and reported that butyrate improved all parameters related to colitis including clinical indices with decreased stool frequency and blood in stool, and endoscopic a…”
MethodTHE COLONIC EPITHELIUM IN ULCERATIVE COLITIS: AN ENERGY-DEFICIENCY DISEASE?
Roediger, W. E. W. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91934-0 · Cited by 719
Vinolo, M. A. R., Rodrigues, H. G., Hatanaka, E., Sato, F. T., Sampaio, S. C., & Curi, R. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.07.009 · Cited by 708 · cited 1×
“By regulating the production of inflammatory mediators, such as TNFα and IL-17, SCFA modify neutrophil recruitment.(62) Neutrophil chemotaxis has been shown to be regulated through the SCFA activation of the GPR43 receptor in neutrophils.”
BackgroundBachem, A., Makhlouf, C., Binger, K. J., de Souza, D. P., Tull, D., Hochheiser, K., Whitney, P. G., Fernandez-Ruiz, D., Dähling, S., Kastenmüller, W., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.002 · Cited by 702 · cited 1×
“Butyrate also improved the memory potential and enhanced recall capacity of CD8+ T memory cells (Tmem) through reprogramming cellular mitochondrial metabolic flux.(98,99) SCFA have also been shown to”
BackgroundTrompette, A., Gollwitzer, E. S., Pattaroni, C., Lopez-Mejia, I. C., Riva, E., Pernot, J., Ubags, N., Fajas, L., Nicod, L. P., & Marsland, B. J. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.022 · Cited by 678 · cited 1×
“In addition to its direct effect on CD4+ T lymphocytes, butyrate also directly modulated gene expression in CD8+ cytotoxic T lymphocytes and altered gene expression of effector molecules such as IFN-γ in a dose dependent manner.(96,97) Butyrate also improved the memory potential and enhanced recall capacity of CD8+ T…”
BackgroundTan, J., McKenzie, C., Vuillermin, P. J., Goverse, G., Vinuesa, C. G., Mebius, R. E., Macia, L., & Mackay, C. R. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.047 · Cited by 667 · cited 1×
“Benefits relating to anaphylaxis scores and IgE concentrations were noted with fiber supplementation, or the addition of acetate or butyrate to animal drinking water, suggesting the production of SCFA from fiber as the mediating effector on mast cells.(73)”
BackgroundSun, M., Wu, W., Chen, L., Yang, W., Huang, X., Ma, C., Chen, F., Xiao, Y., Zhao, Y., Ma, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05901-2 · Cited by 658 · cited 1×
“Th1 cells have been reported to induce severe colitis in mice.(100) Recent studies have also investigated the effect of”
BackgroundNLRP3 Inflammasome and Inflammatory Bowel Disease
Zhen, Y., & Zhang, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00276 · Cited by 649 · cited 5×
“While inflammasomes are protective when intestinal barrier is intact, once the barrier is disrupted by gut dysbiosis, inflammasomes’ activation and recruitment of immune cells are associated with mucosal inflammation – which is another major pathophysiologic mechanism for ongoing inflammation in IBD.(118) Butyrate has…”
BackgroundInfluentialPro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells
Li, M., van Esch, B. C. A. M., Wagenaar, G. T. M., Garssen, J., Folkerts, G., & Henricks, P. A. J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.05.003 · Cited by 614 · cited 1×
“Butyrate suppression of reactive oxygen species through support of the antioxidant system has been suggested as a means for butyrate inactivation of NF-κB inflammatory signaling.(57) In a mouse model of chronic-binge ethanol feeding which induces oxidative stress, tributyrin co-supplementation mitigated losses in gene…”
BackgroundTakahashi, K., Nishida, A., Fujimoto, T., Fujii, M., Shioya, M., Imaeda, H., Inatomi, O., Bamba, S., Andoh, A., & Sugimoto, M. (2016) · Digestion · doi:10.1159/000441768 · Cited by 599 · cited 1×
“of IBD, a reduction in butyrate producing gut microbes has been reported.(107,108) As it has been described in our previous detailed discussion in this review, butyrate has”
Chen, G., Ran, X., Li, B., Li, Y., He, D., Huang, B., Fu, S., Liu, J., & Wang, W. (2018) · eBioMedicine · doi:10.1016/j.ebiom.2018.03.030 · Cited by 580
Rosser, E. C., Piper, C. J. M., Matei, D. E., Blair, P. A., Rendeiro, A. F., Orford, M., Alber, D. G., Krausgruber, T., Catalan, D., Klein, N., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.03.003 · Cited by 579 · cited 1×
“butyrate to have anti-inflammatory properties resulting from induction of IL-10 producing B cells.(101,102) However, conflicting data exist, as other studies which”
ResultImpact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation
Bach Knudsen, K. E., Lærke, H. N., Hedemann, M. S., Nielsen, T. S., Ingerslev, A. K., Gundelund Nielsen, D. S., Theil, P. K., Purup, S., Hald, S., Schioldan, A. G., et al. (2018) · Nutrients · doi:10.3390/nu10101499 · Cited by 572 · cited 1×
“Despite having different ligands, PRRs share signaling pathways that ultimately activate pro-inflammatory transcription factors, such as NF-κB, which controls expression of genes encoding for proinflammatory cytokines, chemokines, inducible inflammatory enzymes, adhesion molecules, growth factors, acute phase proteins…”
BackgroundBenefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
Sivaprakasam, S., Prasad, P. D., & Singh, N. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.007 · Cited by 571 · cited 1×
“Sivaprakasam et al provided a detailed review of SCFA receptors.(39)”
BackgroundHague, A., Manning, A. M., Hanlon, K. A., Hart, D., Paraskeva, C., & Huschtscha, L. I. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550329 · Cited by 530 · cited 1×
“has been shown to induce apoptosis in human colonic cancer cell lines in a p-53 independent pathway.(150)”
BackgroundLazar, V., Ditu, L.-M., Pircalabioru, G. G., Gheorghe, I., Curutiu, C., Holban, A. M., Picu, A., Petcu, L., & Chifiriuc, M. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01830 · Cited by 525 · cited 1×
“to decline again in adulthood and especially in the elderly.(13,14)”
BackgroundPeng, L., He, Z., Chen, W., Holzman, I. R., & Lin, J. (2007) · Pediatric Research · doi:10.1203/01.pdr.0000250014.92242.f3 · Cited by 518 · cited 1×
“Higher butyrate dosing in Caco-2 monolayers (8 mM) was cytotoxic reducing TER, increasing FITC permeability, and inducing apoptosis compared to lower dosing (2 mM).(48) In a mouse model of ethanol exposure, the amount and delivery method of tributyrin, a butyrate prodrug, paradoxically impacted the effect on intestina…”
BackgroundZhao, Y., Chen, F., Wu, W., Sun, M., Bilotta, A. J., Yao, S., Xiao, Y., Huang, X., Eaves-Pyles, T. D., Golovko, G., et al. (2018) · Mucosal Immunology · doi:10.1038/mi.2017.118 · Cited by 515
Agus, A., Denizot, J., Thévenot, J., Martinez-Medina, M., Massier, S., Sauvanet, P., Bernalier-Donadille, A., Denis, S., Hofman, P., Bonnet, R., et al. (2016) · Scientific Reports · doi:10.1038/srep19032 · Cited by 477
Feng, Y., Wang, Y., Wang, P., Huang, Y., & Wang, F. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492853 · Cited by 471 · cited 1×
“During exposure to LPS, butyrate’s protection against LPS-induced TER reduction and paracellular permeability coincided with less activation of NLRP3 inflammasome and autophagy via butyrate’s HDAC activity.(45) Butyrate has also been shown to stabilize hypoxia-inducible factor (HIF), a transcription factor that coordi…”
BackgroundShort-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats
Fukumoto, S., Tatewaki, M., Yamada, T., Fujimiya, M., Mantyh, C., Voss, M., Eubanks, S., Harris, M., Pappas, T. N., & Takahashi, T. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00442.2002 · Cited by 465 · cited 1×
“Laboratory studies suggest that butyrate assists with gut motility(22) by serving as a ligand and activator of SCFA receptors,(23) inducing the gut hormone peptide YY(24) or mediating enterochromaffin cell release of serotonin.(25) Butyrate enhances water and”
BackgroundGeirnaert, A., Calatayud, M., Grootaert, C., Laukens, D., Devriese, S., Smagghe, G., De Vos, M., Boon, N., & Van de Wiele, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-11734-8 · Cited by 451 · cited 1×
“prausnitzii, Butyricicoccus pullicaecorum, and the mix of six butyrateproducers) which improved epithelial barrier integrity in vitro.(122)”
BackgroundGut Microbiome: What We Do and Don't Know
Cresci, G. A., & Bawden, E. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615609899 · Cited by 417
Self-citationThe effect of short-chain fatty acids on human monocyte-derived dendritic cells
Nastasi, C., Candela, M., Bonefeld, C. M., Geisler, C., Hansen, M., Krejsgaard, T., Biagi, E., Andersen, M. H., Brigidi, P., Ødum, N., et al. (2015) · Scientific Reports · doi:10.1038/srep16148 · Cited by 414
Epithelial Toll-like receptors and their role in gut homeostasis and disease
Burgueño, J. F., & Abreu, M. T. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0261-4 · Cited by 395 · cited 2×
“A more detailed review of PRRs can be found in Burgueno et al.(50)”
BackgroundShort-chain fatty acids act as antiinflammatory mediatorsby regulating prostaglandin E2 and cytokines
Cox, M. A., Jackson, J., Stanton, M., Rojas-Triana, A., Bober, L., Laverty, M., Yang, X., Zhu, F., Liu, J., Wang, S., et al. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5549 · Cited by 377
G Protein-Coupled Receptor 43 Is Essential for Neutrophil Recruitment during Intestinal Inflammation
Sina, C., Gavrilova, O., Förster, M., Till, A., Derer, S., Hildebrand, F., Raabe, B., Chalaris, A., Scheller, J., Rehmann, A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900063 · Cited by 376
Diet and the human gut microbiome: An international review
Wilson, A. S., Koller, K. R., Ramaboli, M. C., Nesengani, L. T., Ocvirk, S., Chen, C., Flanagan, C. A., Sapp, F. R., Merritt, Z. T., Bhatti, F., et al. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06112-w · Cited by 369 · cited 2×
“Conversely, diets low in fiber and high in fat and simple carbohydrates have a low SCFA fermenting capacity and are linked with chronic health conditions such as colorectal cancer and cardio-metabolic diseases.(6)”
BackgroundSanchez, H. N., Moroney, J. B., Gan, H., Shen, T., Im, J. L., Li, T., Taylor, J. R., Zan, H., & Casali, P. (2020) · Nature Communications · doi:10.1038/s41467-019-13603-6 · Cited by 361 · cited 1×
“ulation of antibody response by HDAC inhibitory effect and enhancing class-switch DNA recombination, which results in inhibition of autoimmune response.(104) SCFA”
BackgroundESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease
Bischoff, S. C., Escher, J., Hébuterne, X., Kłęk, S., Krznaric, Z., Schneider, S., Shamir, R., Stardelova, K., Wierdsma, N., Wiskin, A. E., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.002 · Cited by 351 · cited 2×
“In 1992 Scheppach et al performed a clinical trial in which 100mMol/L of butyrate via rectal enema was compared with placebo for distal ulcerative colitis and reported that butyrate improved all parameters related to colitis including clinical indices with decreased stool frequency and blood in stool, and endoscopic a…”
BackgroundRegulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate
Luu, M., Weigand, K., Wedi, F., Breidenbend, C., Leister, H., Pautz, S., Adhikary, T., & Visekruna, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-32860-x · Cited by 342 · cited 1×
“In addition to its direct effect on CD4+ T lymphocytes, butyrate also directly modulated gene expression in CD8+ cytotoxic T lymphocytes and altered gene expression of effector molecules such as IFN-γ in a dose dependent manner.(96,97) Butyrate also improved the memory potential and enhanced recall capacity of CD8+ T…”
BackgroundThe microbiome and regulation of mucosal immunity
McDermott, A. J., & Huffnagle, G. B. (2014) · Immunology · doi:10.1111/imm.12231 · Cited by 334 · cited 1×
“plasma cells, CD4+ lamina propria T-cells and intraepithelial αβ T-cell receptor CD8+ cells.(8,9) Angiogenin-4,”
BackgroundShort-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat
Cherbut, C., Ferrier, L., Rozé, C., Anini, Y., Blottière, H., Lecannu, G., & Galmiche, J.-P. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.6.g1415 · Cited by 317
The Microbial Metabolite Butyrate Induces Expression of Th1-Associated Factors in CD4+ T Cells
Kespohl, M., Vachharajani, N., Luu, M., Harb, H., Pautz, S., Wolff, S., Sillner, N., Walker, A., Schmitt-Kopplin, P., Boettger, T., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01036 · Cited by 294 · cited 3×
“1mM to 1mM for in-vitro, and 50mM to 200mM for invivo via oral route) on T cell-mediated immune response utilizing CD4+ T cells.(95) They reported that at lower concentrations (0.”
BackgroundMethodHase, K., Eckmann, L., Leopard, J. D., Varki, N., & Kagnoff, M. F. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.953-963.2002 · Cited by 293 · cited 1×
“AMPs by intestinal epithelial cells through its interaction with GPR43,(59) activation of MEK/ERK and JNK pathways,(60) and its cell proliferation mechanisms.(60)”
BackgroundSCFAs Induce Mouse Neutrophil Chemotaxis through the GPR43 Receptor
Vinolo, M. A. R., Ferguson, G. J., Kulkarni, S., Damoulakis, G., Anderson, K., Bohlooly-Y, M., Stephens, L., Hawkins, P. T., & Curi, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021205 · Cited by 292 · cited 1×
“Neutrophil chemotaxis has been shown to be regulated through the SCFA activation of the GPR43 receptor in neutrophils.(63,64) SCFA may also modify neutrophil functions such as their phagocytic capacity and ability to produce and release reactive oxygen species and nitric oxide.”
BackgroundBreuer, R. I., Soergel, K. H., Lashner, B. A., Christ, M. L., Hanauer, S. B., Vanagunas, A., Harig, J. M., Keshavarzian, A., Robinson, M., Sellin, J. H., et al. (1997) · Gut · doi:10.1136/gut.40.4.485 · Cited by 281 · cited 1×
“Other clinical trials which followed reported mixed results, ranging from no to some butyrate effectiveness, although not at the degree of therapeutic value.(134,135)”
BackgroundBandeira, A., Mota-Santos, T., Itohara, S., Degermann, S., Heusser, C., Tonegawa, S., & Coutinho, A. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.1.239 · Cited by 280 · cited 1×
“plasma cells, CD4+ lamina propria T-cells and intraepithelial αβ T-cell receptor CD8+ cells.(8,9) Angiogenin-4,”
BackgroundVeettil, S. K., Wong, T. Y., Loo, Y. S., Playdon, M. C., Lai, N. M., Giovannucci, E. L., & Chaiyakunapruk, N. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.37341 · Cited by 275 · cited 1×
“cer risk with dietary pattern and specifically with a low fiber, high fat and simple sugar containing diet.(159,160) Although there are several possible theories through”
Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease
BISCHOFF, S. C., WEDEMEYER, J., HERRMANN, A., MEIER, P. N., TRAUTWEIN, C., CETIN, Y., MASCHEK, H., STOLTE, M., GEBEL, M., & MANNS, M. P. (1996) · Histopathology · doi:10.1046/j.1365-2559.1996.262309.x · Cited by 261
Lee, C., Kim, B. G., Kim, J. H., Chun, J., Im, J. P., & Kim, J. S. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.07.023 · Cited by 260 · cited 1×
“ing pathway, butyrate has been shown to modulate proinflammatory cytokine production.(21,26)”
BackgroundButyrate and the Colonocyte: Production, Absorption, Metabolism, and Therapeutic Implications
Velázquez, O. C., Lederer, H. M., & Rombeau, J. L. (1997) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-5967-2_14 · Cited by 258
Barclay, A. R., Russell, R. K., Wilson, M. L., Gilmour, W. H., Satsangi, J., & Wilson, D. C. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.03.017 · Cited by 248 · cited 3×
“Early life exposures such as breastfeeding has been reported to have a protective role against development and pathogenesis of IBD.(115) Gao et al studied this mechanism further and analyzed this effect by utilizing immature human enterocytes.”
BackgroundInfluentialAoyama, M., Kotani, J., & Usami, M. (2010) · Nutrition · doi:10.1016/j.nut.2009.07.006 · Cited by 245 · cited 1×
“Butyrate and propionate induce apoptosis in both activated and non-activated neutrophils, which depends on activation of caspases but not Gαi/o and Gαq pathways, suggesting independence of SCFA receptors.(66)”
BackgroundElhaseen E., E., Ad A., M., Jan, D., Harm-Jan, P., & Daisy M., J. (2013) · The Journal of Nutrition · doi:10.3945/jn.113.179549 · Cited by 238 · cited 1×
“Increased TJ reassembly and TER restoration was due to butyrate’s induction of AMP-activated protein kinase (AMPK) activity.(41,43,46) During exposure to LPS, butyrate’s protection against LPS-induced TER reduction and paracellular permeability coincided with less activation of NLRP3 inflammasome and autophagy via but…”
BackgroundKaisar, M. M. M., Pelgrom, L. R., van der Ham, A. J., Yazdanbakhsh, M., & Everts, B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01429 · Cited by 238 · cited 3×
“chondrial oxygen consumption rate in butyrate treated DC at baseline.(93)”
BackgroundAn umbrella review of the evidence associating diet and cancer risk at 11 anatomical sites
Papadimitriou, N., Markozannes, G., Kanellopoulou, A., Critselis, E., Alhardan, S., Karafousia, V., Kasimis, J. C., Katsaraki, C., Papadopoulou, A., Zografou, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24861-8 · Cited by 234 · cited 1×
“cer risk with dietary pattern and specifically with a low fiber, high fat and simple sugar containing diet.(159,160) Although there are several possible theories through”
BackgroundTreatment of left‐sided ulcerative colitis with butyrate enemas: a controlled trial
STEINHART, A. H., HIRUKI, T., BRZEZINSKI, A., & BAKER, J. P. (1996) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1996.d01-509.x · Cited by 221 · cited 1×
“Other clinical trials which followed reported mixed results, ranging from no to some butyrate effectiveness, although not at the degree of therapeutic value.(134,135)”
BackgroundMILLARD, A. L., MERTES, P. M., ITTELET, D., VILLARD, F., JEANNESSON, P., & BERNARD, J. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.0009-9104.2002.01977.x · Cited by 220 · cited 5×
“Butyrate treatment is reported to have a significant impact on differentiation, maturation, and overall T lymphocyte stimulating effects of human monocyte derived DC.86,90 In vitro studies found butyrate in the presence of inducers (eg, LPS, TNF-α) affected the differentiation of DC and induced an immunosuppressive ef…”
BackgroundInfluentialDoes butyrate protect from colorectal cancer?
Sengupta, S., Muir, J. G., & Gibson, P. R. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04213.x · Cited by 219 · cited 1×
“healthy cells in homeostasis, but suppressing the hyperproliferation induced by cancer.(112,148,149) Sodium butyrate”
BackgroundButyrate enema therapy stimulates mucosal repair in experimental colitis in the rat.
Butzner, J. D., Parmar, R., Bell, C. J., & Dalal, V (1996) · Gut · doi:10.1136/gut.38.4.568 · Cited by 213
Narula, N., Kassam, Z., Yuan, Y., Colombel, J.-F., Ponsioen, C., Reinisch, W., & Moayyedi, P. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001228 · Cited by 211
Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats
Zhang, M., Zhou, Q., Dorfman, R. G., Huang, X., Fan, T., Zhang, H., Zhang, J., & Yu, C. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0500-x · Cited by 209 · cited 3×
“In a DSSinduced colitis model in male outbred-CD-1 mice, the dietary provision of baked corn and bean snack (20–40 g/kg body weight) resulted in the highest concentration of butyrate in the cecum and feces, and an anti-inflammatory effect by downregulating IL-1 receptor, TLR receptors and TNF-alpha pathways.123 Smith…”
ResultInfluentialFiber Intake and Survival After Colorectal Cancer Diagnosis
Song, M., Wu, K., Meyerhardt, J. A., Ogino, S., Wang, M., Fuchs, C. S., Giovannucci, E. L., & Chan, A. T. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3684 · Cited by 197 · cited 1×
“reported reduced risk of colorectal cancer recurrence.(157,158) Recent extensive meta-analyses' have confirmed these trends and reported a strong association of colorectal can-”
BackgroundButyrate reduces colonic paracellular permeability by enhancing PPARγ activation
Kinoshita, M., Suzuki, Y., & Saito, Y. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00294-2 · Cited by 194 · cited 1×
“The nuclear transcription factor PPARγ, which antagonizes NF-κB, was reported to be upregulated by butyrate in HT-29 colonic epithelial cells.(56) Butyrate suppression of reactive oxygen species through support of the antioxidant system has been suggested as a means for butyrate inactivation of NF-κB inflammatory sign…”
BackgroundHamer, H. M., Jonkers, D. M. A. E., Vanhoutvin, S. A. L. W., Troost, F. J., Rijkers, G., de Bruïne, A., Bast, A., Venema, K., & Brummer, R.-J. M. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.04.002 · Cited by 193 · cited 1×
“Hamer et al studied the effect of butyrate in low grade inflammation in ulcerative colitis patients in remission, and reported only minor improvements in inflammatory and oxidative stress parameters after rectal enema of 10mM sodium butyrate for 20 days.(136) In a systematic review and meta-analysis of eight randomize…”
BackgroundHu, S., Liu, L., Chang, E. B., Wang, J.-Y., & Raufman, J.-P. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0450-x · Cited by 184 · cited 1×
“of mitogen-activated protein kinase (MAPK) signaling pathway,(152) differential regulation of Wnt-β-catenin signaling pathway,(153,154) and upregulation of microRNA miR-203 and promotion of cell apoptosis,(155) and inhibition of pro-proliferative miR-92a.(156) Due to a well-”
BackgroundAGA technical review: Impact of dietary fiber on colon cancer occurrence
Kim, Y. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70377-5 · Cited by 182 · cited 1×
“important intermediary metabolite in this pathway.(140,161,162) More research is needed to show the”
BackgroundButyrate interferes with the differentiation and function of human monocyte-derived dendritic cells
Liu, L., Li, L., Min, J., Wang, J., Wu, H., Zeng, Y., Chen, S., & Chu, Z. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.05.011 · Cited by 172 · cited 9×
“the expression of tight junctional proteins and supporting intestinal mucus production.(19,21) Laboratory studies suggest that butyrate assists with gut motility(22) by serving as a ligand and activator of SCFA receptors,(23) inducing the gut hormone peptide YY(24) or mediating enterochromaffin cell release of seroton…”
BackgroundInfluentialGelbmann, C. M., Mestermann, S., Gross, V, Köllinger, M., Schölmerich, J., & Falk, W. (1999) · Gut · doi:10.1136/gut.45.2.210 · Cited by 169
Mirmonsef, P., Zariffard, M. R., Gilbert, D., Makinde, H., Landay, A. L., & Spear, G. T. (2012) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2011.01089.x · Cited by 166 · cited 1×
“cing IL-1β, IL-6, CXCL8/IL-8 in human peripheral blood mononuclear cells.(67) Thus, the divergences on the inflammatory effects of butyrate appears to depend on the cell type studied and the conditions, environment, and type of stimulation.”
BackgroundDass, N. B., John, A. K., Bassil, A. K., Crumbley, C. W., Shehee, W. R., Maurio, F. P., Moore, G. B. T., Taylor, C. M., & Sanger, G. J. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00853.x · Cited by 166
Germinated barley foodstuff prolongs remission in patients with ulcerative colitis
Hanai, H., Kanauchi, O., Mitsuyama, K., Andoh, A., Takeuchi, K., Takayuki, I., Araki, Y., Fujiyama, Y., Toyonaga, A., Sata, M., et al. (2004) · International Journal of Molecular Medicine · doi:10.3892/ijmm.13.5.643 · Cited by 165 · cited 1×
“Germinated barley, a prebiotic that is fermented into SCFA, reduced colonic mast cell recruitment when fed to rats in an experimental colitis model;(75) and ulcerative colitis patients fed germinated barley had reduced inflammation and an improved clinical activity index.(76,77) When testing the direct effects of buty…”
BackgroundGurav, A., Sivaprakasam, S., Bhutia, Y. D., Boettger, T., Singh, N., & Ganapathy, V. (2015) · Biochemical Journal · doi:10.1042/bj20150242 · Cited by 164 · cited 1×
“Through activation of GPR109a in macrophages and DC, butyrate plays a key role in maintenance of proand anti-inflammatory T lymphocytes, as butyrate potentiates conversion of naïve T cells to FoxP3+ regulatory T cells while suppressing IFN-γ+ T cells.(33,87) Kaiser et al also reported that butyrate rendered DC metabol…”
BackgroundCresci, G. A., Thangaraju, M., Mellinger, J. D., Liu, K., & Ganapathy, V. (2010) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-009-1045-x · Cited by 164
Self-citationFecal transplantation for treatment of inflammatory bowel disease
Imdad, A., Nicholson, M. R., Tanner-Smith, E. E., Zackular, J. P., Gomez-Duarte, O. G., Beaulieu, D. B., & Acra, S. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012774.pub2 · Cited by 164
Physiological and Anti‐Inflammatory Roles of Dietary Fiber and Butyrate in Intestinal Functions
Andoh, A., Bamba, T., & Sasaki, M. (1999) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719902300518 · Cited by 162
Fecal transplantation for treatment of inflammatory bowel disease
Imdad, A., Nicholson, M. R., Tanner-Smith, E. E., Zackular, J. P., Gomez-Duarte, O., Borromeo Beaulieu, D. M., & Acra, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012774 · Cited by 158
Nastasi, C., Fredholm, S., Willerslev-Olsen, A., Hansen, M., Bonefeld, C. M., Geisler, C., Andersen, M. H., Ødum, N., & Woetmann, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-15099-w · Cited by 157
Early‐Life Gut Microbiome—The Importance of Maternal and Infant Factors in Its Establishment
Kapourchali, F. R., & Cresci, G. (2020) · Nutrition in Clinical Practice · doi:10.1002/ncp.10490 · Cited by 151 · cited 1×
“While gut colonization begins in utero, the first major colonization occurs and varies with the mode of infant delivery, vaginal versus Cesarean section, and the method of infant feeding, breast milk versus infant formula.(4) Within the first 2–3 years”
BackgroundSelf-citationRosignoli, P. (2001) · Carcinogenesis · doi:10.1093/carcin/22.10.1675 · Cited by 147 · cited 2×
“tive stress in both human and rat-derived colonocyte cultures.(113,114) Early life exposures such as breastfeeding has been reported to have a protective role against development and pathogenesis of IBD.”
BackgroundCresci, G. A., Glueck, B., McMullen, M. R., Xin, W., Allende, D., & Nagy, L. E. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13731 · Cited by 146 · cited 1×
“Impaired intestinal barrier function and increased permeability is considered one of the key mechanisms in development of IBD, and as discussed earlier butyrate supplementation has been shown to mitigate this effect in multiple in-vitro animal models.(42,126) In IL-10 deficient mice which are prone to development of c…”
BackgroundSelf-citationProbiotics, Prebiotics and Synbiotics in Inflammatory Bowel Diseases
Akutko, K., & Stawarski, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112466 · Cited by 144
Kanauchi, O., Mitsuyama, K., Homma, T., Takahama, K., Fujiyama, Y., Andoh, A., Araki, Y., Suga, T., Hibi, T., Naganuma, M., et al. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.12.5.701 · Cited by 137 · cited 1×
“Germinated barley, a prebiotic that is fermented into SCFA, reduced colonic mast cell recruitment when fed to rats in an experimental colitis model;(75) and ulcerative colitis patients fed germinated barley had reduced inflammation and an improved clinical activity index.(76,77) When testing the direct effects of buty…”
BackgroundButyrate enemas in experimental colitis and protection against large bowel cancer in a rat model
D’Argenio, G., Cosenza, V., Cave, M. D., Iovino, P., Valle, N. D., Lombardi, G., & Mazzacca, G. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8964397 · Cited by 136 · cited 1×
“healthy cells in homeostasis, but suppressing the hyperproliferation induced by cancer.(112,148,149) Sodium butyrate”
BackgroundAbrahamse, S. L., Pool-Zobel, B. L., & Rechkemmer, G. (1999) · Carcinogenesis · doi:10.1093/carcin/20.4.629 · Cited by 135 · cited 1×
“tive stress in both human and rat-derived colonocyte cultures.(113,114) Early life exposures such as breastfeeding has been reported to have a protective role against development and pathogenesis of IBD.”
BackgroundAlberts, D. S., Ritenbaugh, C., Story, J. A., Aickin, M., Rees-McGee, S., Buller, M. K., Atwood, J., Phelps, J., Ramanujam, P. S., Bellapravalu, S., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.2.81 · Cited by 132 · cited 1×
“reported reduced risk of colorectal cancer recurrence.(157,158) Recent extensive meta-analyses' have confirmed these trends and reported a strong association of colorectal can-”
BackgroundProtective Mechanisms of Butyrate on Inflammatory Bowel Disease
Silva, J. P. B., Navegantes-Lima, K. C., Oliveira, A., Rodrigues, D. V. S., Gaspar, S. L. D. F., Monteiro, V. S., Moura, D. P., & Monteiro, M. C. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612824666181001153605 · Cited by 132 · cited 2×
“Since the late 20th century when the implication of butyrate in colitis was first highlighted, a series of experimental and clinical studies have been conducted.(110,111)”
BackgroundBailón, E., Cueto-Sola, M., Utrilla, P., Rodríguez‐Cabezas, M. E., Garrido‐Mesa, N., Zarzuelo, A., Xaus, J., Gálvez, J., & Comalada, M. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.01.001 · Cited by 130 · cited 1×
“Thus, the divergences on the inflammatory effects of butyrate appears to depend on the cell type studied and the conditions, environment, and type of stimulation.(68)”
BackgroundFatty acids as modulators of neutrophil recruitment, function and survival
Rodrigues, H. G., Takeo Sato, F., Curi, R., & Vinolo, M. A. R. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.098 · Cited by 124 · cited 1×
“SCFA may also modify neutrophil functions such as their phagocytic capacity and ability to produce and release reactive oxygen species and nitric oxide.(65) Butyrate and propionate induce apoptosis in both activated and non-activated neutrophils, which depends on activation of caspases but not Gαi/o and Gαq pathways,…”
BackgroundSauer, J., Richter, K. K., & Pool-Zobel, B. L. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.12.012 · Cited by 124 · cited 1×
“levels, and improved detoxification of hydrogen peroxide (H2O2) by induction of catalase.(109,110) Since the late 20th century when the implication of butyrate in colitis was first highlighted, a series of experimental and clinical studies have been conducted.”
BackgroundSingh, B. (1997) · Carcinogenesis · doi:10.1093/carcin/18.6.1265 · Cited by 124
Gao, Y., Davis, B., Zhu, W., Zheng, N., Meng, D., & Walker, W. A. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00279.2020 · Cited by 122
Yu, D. C., Waby, J. S., Chirakkal, H., Staton, C. A., & Corfe, B. M. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-276 · Cited by 117
Short chain fatty acids in plasma and brain: Quantitative determination by gas chromatography
Bachmann, C., Colombo, J.-P., & Berüter, J. (1979) · Clinica Chimica Acta · doi:10.1016/0009-8981(79)90109-8 · Cited by 115 · cited 1×
“0 pmol/ mg of brain tissue in humans.(20) Butyrate supports the”
BackgroundNielsen, D. S. G., Jensen, B. B., Theil, P. K., Nielsen, T. S., Knudsen, K. E. B., & Purup, S. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2017.10.023 · Cited by 115 · cited 1×
“In vitro studies with E12 mucus-producing epithelial cells demonstrated that lower (1–10 mM), but not higher (50–100 mM), butyrate dosing prevented alterations in TER, FITC-dextran permeability, and mucus production by goblet cells.(44) Higher butyrate dosing in Caco-2 monolayers (8 mM) was cytotoxic reducing TER, inc…”
BackgroundIL-22: There Is a Gap in Our Knowledge
Zenewicz, L. A. (2018) · ImmunoHorizons · doi:10.4049/immunohorizons.1800006 · Cited by 115 · cited 1×
“IL-22 aids in protecting the intestine against inflammatory injury by inducing AMPs and supporting the intestinal barrier.(84,85)”
BackgroundDietary Fermentable Fiber Reduces Intestinal Barrier Defects and Inflammation in Colitic Mice
Hung, T. V., & Suzuki, T. (2016) · Journal of Nutrition · doi:10.3945/jn.116.232538 · Cited by 114 · cited 1×
“Similarly, prebiotics tested in mouse models of colitis which led to increased fecal SCFA levels were linked with protection of the intestinal barrier, and a reduction in inflammation and inflammatory cytokines.(74)”
BackgroundTributyrin Supplementation Protects Mice from Acute Ethanol-Induced Gut Injury
Cresci, G. A., Bush, K., & Nagy, L. E. (2014) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12428 · Cited by 113 · cited 2×
“Higher doses (10 mM) provided daily in the food supply increased liver injury and steatosis compared to lower doses provided by oral gavage, despite both methods and doses protecting against ethanol-induced disassembly of intestinal TJ proteins.(41) Together, these data support the notion that butyrate has a direct be…”
BackgroundSelf-citationLinking Innate to Adaptive Immunity through Dendritic Cells
Steinman, R. M. (2006) · Novartis Foundation symposium · doi:10.1002/9780470035399.ch9 · Cited by 112 · cited 1×
“In the intestine, DC induce adaptive immune responses in primary T cells bridging the gap between innate and adaptive immunity.(91,92) Immature DC help maintain a state of immune tolerance, and mature DC can activate immune responses.”
BackgroundLuceri, C., Femia, A. P., Fazi, M., Martino, C. D., Zolfanelli, F., Dolara, P., & Tonelli, F. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.09.005 · Cited by 105 · cited 2×
“Although surgical treatment with either reconnection or resection of the diverted colon is a more definitive treatment, butyrate enema has been shown to have therapeutic value when medical management is considered.(140) It should be noted that due to overall discrepancy in the evidence, there remains a lack of SCFA or…”
BackgroundThe role of butyrate in surgical and oncological outcomes in colorectal cancer
Hajjar, R., Richard, C. S., & Santos, M. M. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00316.2020 · Cited by 104 · cited 1×
“important intermediary metabolite in this pathway.(140,161,162) More research is needed to show the”
BackgroundWang, C. C., Wu, H. C., Lin, F. H., Gong, R., Xie, F., Peng, Y., Feng, J., & Hu, C. H. (2017) · Innate Immunity · doi:10.1177/1753425917741970 · Cited by 102 · cited 1×
“When testing the direct effects of butyrate on mast cells, jejunal mucosa of pigs treated with butyrate had reduced mast cell degranulation and gene expression of proinflammatory cytokines.(78) These data corroborate a previous report demonstrating that the direct effect of butyrate on mast cells was due to the MAPK s…”
BackgroundWen, X., Wang, H., Zhang, M., Zhang, M., Wang, H., & Yang, X. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i21.2834 · Cited by 100 · cited 1×
“Burrello et al reported that fecal microbiota transplantation with healthy stool in mice exposed to chronic intestinal inflammation decreased colonic inflammation, effects which are mediated through T cell modulation.(131,132)”
BackgroundBurrello, C., Giuffrè, M. R., Macandog, A. D. G., Díaz‐Basabe, A., Cribiù, F. M., Lopez, G., Borgo, F., Nezi, L., Caprioli, F., Vecchi, M. L., et al. (2019) · Cells · doi:10.3390/cells8060517 · Cited by 98
Mishiro, T., Kusunoki, R., Otani, A., Ansary, M. M. U., Tongu, M., Harashima, N., Yamada, T., Sato, S., Amano, Y., Itoh, K., et al. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.70 · Cited by 97
Fecal microbiota transplantation therapy in Crohn's disease: Systematic review
Fehily, S. R., Basnayake, C., Wright, E. K., & Kamm, M. A. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15598 · Cited by 95
Kim, D. S., Woo, J. S., Min, H.-K., Choi, J., Moon, J. H., Park, M.-J., Kwok, S., Park, S., & Cho, M. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102611 · Cited by 93
Mast cells in gastrointestinal disorders
Bischoff, S. C. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.02.018 · Cited by 92
Butyrate modulates intestinal epithelial cell-mediated neutrophil migration
BÖCKER, U., NEBE, T., HERWECK, F., HOLT, L., PANJA, A., JOBIN, C., ROSSOL, S., SARTOR, R. B., & SINGER, M. V. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2003.02056.x · Cited by 91 · cited 3×
“other treatment modalities of IBD.(120,121) Geirnaert et al aug-”
BackgroundInfluentialKim, S.-H., Cho, B.-H., Kiyono, H., & Jang, Y.-S. (2017) · Scientific Reports · doi:10.1038/s41598-017-02729-6 · Cited by 91
Song, M., Xia, B., & Li, J. (2006) · Postgraduate Medical Journal · doi:10.1136/pgmj.2005.037945 · Cited by 90
Diversion colitis and pouchitis: A mini-review
Tominaga, K., Kamimura, K., Takahashi, K., Yokoyama, J., Yamagiwa, S., & Terai, S. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i16.1734 · Cited by 90 · cited 1×
“One area in which butyrate has shown more consistent effectiveness is in cases of diversion colitis, a post-surgical manifestation when a part of colon is out of continuity and butyrate depletion is thought to be the major factor for driving inflammation.(139) Although surgical treatment with either reconnection or re…”
BackgroundGut-derived acetate promotes B10 cells with antiinflammatory effects
Daïen, C. I., Tan, J., Audo, R., Mielle, J., Quek, L. E., Krycer, J. R., Angelatos, A., Duraes, M., Pinget, G., Ni, D., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.144156 · Cited by 87 · cited 2×
“et al showed that the SCFA acetate promoted B10 cell which resulted in an anti-inflammatory effect.(103) Butyrate”
BackgroundA. Venkatraman, B. S. R. (2000) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655200451171 · Cited by 83 · cited 1×
“Impaired intestinal barrier function and increased permeability is considered one of the key mechanisms in development of IBD, and as discussed earlier butyrate supplementation has been shown to mitigate this effect in multiple in-vitro animal models.(42,126) In IL-10 deficient mice which are prone to development of c…”
BackgroundVernero, M., BLASIO, F. D., Ribaldone, D. G., Bugianesi, E., Pellicano, R., Saracco, G. M., Astegiano, M., & Caviglia, G. P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123941 · Cited by 83 · cited 1×
“Due to inconsistencies in the response of butyrate therapy, perhaps at some degree due to variability in dosages, duration and a standardization of the formula, current applicability of butyrate in IBD is considered as an add-on supplementary therapy at best.(121,138) One area in which butyrate has shown more consiste…”
BackgroundButyrate modulating effects on pro-inflammatory pathways in human intestinal epithelial cells
Elce, A., Amato, F., Zarrilli, F., Calignano, A., Troncone, R., Castaldo, G., & Canani, R. B. (2017) · Beneficial Microbes · doi:10.3920/bm2016.0197 · Cited by 81
Gpr109a Limits Microbiota-Induced IL-23 Production To Constrain ILC3-Mediated Colonic Inflammation
Bhatt, B., Zeng, P., Zhu, H., Sivaprakasam, S., Li, S., Xiao, H., Dong, L., Shiao, S.-Y. P. K., Kolhe, R. B., Patel, N., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701625 · Cited by 77 · cited 1×
“Further studies showed that Gpr109adependent signaling suppressed IL-23 production from dendritic cells and reduced colonic inflammation.(37) Presence of GPR109a was also shown to protect against experimental Escherichia coli (ETEC) infection, secretory IgA responses, and intestinal barrier integrity.”
BackgroundRegulation of colonic epithelial butyrate transport: Focus on colorectal cancer
Gonçalves, P., & Martel, F. (2016) · Porto Biomedical Journal · doi:10.1016/j.pbj.2016.04.004 · Cited by 65 · cited 1×
“proton-coupled monocarboxylate transporter 1 (MCT1; encoded by SLC16A1).(15) Expression of SCFA transporters”
BackgroundA Designer Synbiotic Attenuates Chronic-Binge Ethanol-Induced Gut-Liver Injury in Mice
Roychowdhury, S., Glueck, B., Han, Y., Mohammad, M. A., & Cresci, G. A. M. (2019) · Nutrients · doi:10.3390/nu11010097 · Cited by 62
Self-citationZuo, L., Lu, M., Zhou, Q., Wei, W., & Wang, Y. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.10.028 · Cited by 58
The two faces of mast cells in food allergy and allergic asthma: The possible concept of Yin Yang
Kraneveld, A. D., Sagar, S., Garssen, J., & Folkerts, G. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.013 · Cited by 55
The short-chain fatty acid receptor GPR43 is transcriptionally regulated by XBP1 in human monocytes
Ang, Z., Er, J. Z., & Ding, J. L. (2015) · Scientific Reports · doi:10.1038/srep08134 · Cited by 47
Butyrate Enemas Improve Intestinal Anastomotic Strength in a Rat Model
Bloemen, J. G., Schreinemacher, M. H. F., de Bruïne, A. P., Buurman, W. A., Bouvy, N. D., & Dejong, C. H. C. (2010) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181d881b7 · Cited by 44
Butyrate in Inflammatory Bowel Disease Therapy
Chen, J., & Vitetta, L. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.08.064 · Cited by 44 · cited 4×
“other treatment modalities of IBD.(120,121) Geirnaert et al aug-”
BackgroundInfluentialGong, Y., Jin, X., Yuan, B., Lv, Y., Yan, G., Liu, M., Xie, C., Liu, J., Tang, Y., Gao, H., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583652 · Cited by 44 · cited 1×
“Presence of GPR109a was also shown to protect against experimental Escherichia coli (ETEC) infection, secretory IgA responses, and intestinal barrier integrity.(38) Sivaprakasam et al provided a detailed review of SCFA receptors.”
BackgroundButyrate induced changes in Wnt-signaling specific gene expression in colorectal cancer cells
Lazarova, D. L., Chiaro, C., & Bordonaro, M. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-226 · Cited by 43
Jamka, M., Kokot, M., Kaczmarek, N., Bermagambetova, S., Nowak, J. K., & Walkowiak, J. (2020) · Complementary Medicine Research · doi:10.1159/000512952 · Cited by 43 · cited 2×
“In a systematic review and meta-analysis of eight randomized clinical trials on a total of 227 patients with UC, Jamka et al reported that current limited evidence does not support the use of butyrate enemas in UC.(137) Due to inconsistencies in the response of butyrate therapy, perhaps at some degree due to variabili…”
MethodFunctional Ambivalence of Dendritic Cells: Tolerogenicity and Immunogenicity
Nam, J.-H., Lee, J., Choi, S.-Y., Jung, N.-C., Song, J. Y., Seo, H. G., & Lim, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094430 · Cited by 42 · cited 1×
“In the intestine, DC induce adaptive immune responses in primary T cells bridging the gap between innate and adaptive immunity.(91,92) Immature DC help maintain a state of immune tolerance, and mature DC can activate immune responses.”
BackgroundZhang, T., Ding, C., Zhao, M., Dai, X., Yang, J., Li, Y., Gu, L., Wei, Y., Gong, J., Zhu, W., et al. (2016) · Nutrients · doi:10.3390/nu8120728 · Cited by 36
The Level Short Chain Fatty Acids and HSP 70 in Colorectal Cancer and Non-Colorectal Cancer
Yusuf, F., Adewiah, S., & Fatchiyah, F. (2018) · Acta Informatica Medica · doi:10.5455/aim.2018.26.160-163 · Cited by 36 · cited 1×
“Patients with colorectal cancer have been reported to have low levels of SCFA including butyrate.(147) As mentioned, butyrate has been reported to have a paradoxical effect on the proliferation of intestinal epithelial cells, supporting”
BackgroundLuzardo-Ocampo, I., Campos-Vega, R., de Mejía, E. G., & Loarca-Piña, G. F. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109097 · Cited by 33 · cited 1×
“In a DSSinduced colitis model in male outbred-CD-1 mice, the dietary provision of baked corn and bean snack (20–40 g/kg body weight) resulted in the highest concentration of butyrate in the cecum and feces, and an anti-inflammatory effect by downregulating IL-1 receptor, TLR receptors and TNF-alpha pathways.(123) Smit…”
Backgroundn-Butyrate inhibits Jun NH(2)-terminal kinase activation and cytokine transcription in mast cells
Diakos, C., Prieschl, E. E., Säemann, M. D., Böhmig, G. A., Csonga, R., Sobanov, Y., Baumruker, T., & Zlabinger, G. J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.117 · Cited by 29 · cited 1×
“These data corroborate a previous report demonstrating that the direct effect of butyrate on mast cells was due to the MAPK signaling pathway and inhibition of JNK phosphorylation.(79)”
ResultLuzardo‐Ocampo, I., Loarca-Piña, G. F., & de Mejía, E. G. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111835 · Cited by 29 · cited 1×
“Butyrate has been shown to modulate pro-inflammatory signals and inhibit several nucleotide-binding oligomerization domain-like receptor-3 (NLRP3) inflammasome markers in an in vitro co-culture model of intestinal inflammation.(118,119) One study reported that butyrate significantly reduced IL-8 secretion, and therefo…”
BackgroundGlueck, B., Han, Y., & Cresci, G. (2018) · Journal of Immunology Research · doi:10.1155/2018/9671919 · Cited by 28 · cited 2×
“In a mouse model of chronic-binge ethanol feeding which induces oxidative stress, tributyrin co-supplementation mitigated losses in gene expression of superoxide dismutase 2 (SOD2), thioredoxin (TRX1) and protected against ethanol-induced NOX1.(58)”
BackgroundSelf-citationInnate Immunity Modulation by the IL-33/ST2 System in Intestinal Mucosa
García-Miguel, M., González, M. J., Quera, R., & Hermoso, M. A. (2012) · BioMed Research International · doi:10.1155/2013/142492 · Cited by 18 · cited 1×
“to decline again in adulthood and especially in the elderly.(13,14)”
BackgroundAraki, Y., Kanauchi, O., Sugihara, H., Fujiyama, Y., & Hattori, T. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.2.257 · Cited by 17
Sweet Memories of 8 Empowered by Butyrate
Ji, L., & Hu, X. (2019) · Immunity · doi:10.1016/j.immuni.2019.07.005 · Cited by 4 · cited 1×
“Butyrate also improved the memory potential and enhanced recall capacity of CD8+ T memory cells (Tmem) through reprogramming cellular mitochondrial metabolic flux.(98,99) SCFA have also been shown to”
Background
Research works printed but not linked: 8
- Shi, 2017, Mil Med Res, 4, 14
- Cherbut, 1998, Am J Physiol, 275, G1415
- Araki, 2007, Int J Mol Med, 19, 257
- Kanauchi, 2003, Int J Mol Med, 12, 701
- Hanai, 2004, Int J Mol Med, 13, 643
- Steinman, 2006, Novartis Found Symp, 279
- Jamka, 2020, Complement Med Res, 28, 1
- Imdad, 2018, Cochrane Database Syst Rev, 11, Cd012774
Cited by
The interplay between diet and the gut microbiome: implications for health and disease
Ross, F. C., Patangia, D., Grimaud, G., Lavelle, A., Dempsey, E. M., Ross, R. P., & Stanton, C. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01068-4 · Cited by 638
“Butyrate acts as an energy source for colonocytes, mediates anti-inflammatory properties through intestinal cells (macrophages and dendritic cells) and enhances mucus production, which highlights its role in intestinal homoeostasis optimizing nutrient absorption and gut barrier function 37 .”
Mechanisms of Blood–Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids
Fock, E., & Parnova, R. (2023) · Cells · doi:10.3390/cells12040657 · Cited by 385
Facchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., De Barba, C., Barberio, B., Zingone, F., Maniero, D., Scarpa, M., Ruffolo, C., et al. (2024) · Life · doi:10.3390/life14050559 · Cited by 380
“It not only enhances the integrity of epithelial tissue but also mitigates mucosal inflammation while promoting electrolyte absorption [4].”
BackgroundThe promotion mechanism of prebiotics for probiotics: A review
You, S., Ma, Y., Yan, B., Pei, W., Wu, Q., Ding, C., & Huang, C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1000517 · Cited by 295
The gut virome: A new microbiome component in health and disease
Cao, Z., Sugimura, N., Burgermeister, E., Ebert, M. P., Zuo, T., & Lan, P. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104113 · Cited by 291
Metadata
- Authors
- Siddiqui, M. T., & Cresci, G. A.
- Affiliations
- Cleveland Clinic (US)
- Corresponding author
- Cresci, Gail AM
- Venue
- Journal of Inflammation Research
- Publisher
- Informa UK Limited
- Published
- 2021-11
- Volume
- Volume 14
- Pages
- 6025-6041
- ISSN
- 1178-7031 (ISSN-L)
- PMC
- PMC8608412
- OpenAlex
- W3212258323
- Cited by
- 381
- References
- 164
- Citations by year
- 2026: 93 · 2025: 96 · 2024: 101 · 2023: 59 · 2022: 32
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Inflammation Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (R01AA028043)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK083251)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Keywords
- butyrate, short-chain fatty acids, gut microbiota, intestinal immunity, immunomodulation, immune homeostasis, intestinal inflammation, butyrate supplementation, inflammatory bowel disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.